Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma

• Gaurav Agarwal,
• Sally Moore,
• Ross Sadler,
• Sherin Varghese,
• Alison Turner,
• Lucia Y Chen,
• Jemma Larham,
• Nathanael Gray,
• Oluremi Carty,
• Joe Barrett,
• Constantinos Koshiaris,
• Jaimal Kothari,
• Stella Bowcock,
• Udo Oppermann,
• Vicky Gamble,
• Gordon Cook,
• Chara Kyriakou,
• Mark Drayson,
• Supratik Basu,
• Sarah McDonald,
• Shelagh McKinley,
• Sarah Gooding,
• Muhammad K Javaid,
• Karthik Ramasamy

Affiliations

Gaurav Agarwal

Division of Haematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA

Sally Moore

Bath Royal United Hospitals, Bath

Ross Sadler

Oxford University Hospitals NHS Trust, Oxford

Sherin Varghese

Oxford University Hospitals NHS Trust, Oxford

Alison Turner

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford

Lucia Y Chen

Oxford University Hospitals NHS Trust, Oxford

Jemma Larham

Oxford University Hospitals NHS Trust, Oxford

Nathanael Gray

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford

Oluremi Carty

Oxford University Hospitals NHS Trust, Oxford

Joe Barrett

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford

Constantinos Koshiaris

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford

Jaimal Kothari

Oxford University Hospitals NHS Trust, Oxford

Stella Bowcock

King’s College Hospital NHS Trust, London

Udo Oppermann

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford

Vicky Gamble

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford

Gordon Cook

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds

Chara Kyriakou

University College London Hospitals NHS Trust, London

Mark Drayson

University of Birmingham, Birmingham

Supratik Basu

The Royal Wolverhampton NHS Trust, Wolverhampton, UK; University of Wolverhampton, Wolverhampton

Sarah McDonald

Blood Cancer UK, London

Shelagh McKinley

Myeloma UK, Edinburgh

Sarah Gooding

Oxford University Hospitals NHS Trust, Oxford, UK; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine

Muhammad K Javaid

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford

Karthik Ramasamy

Oxford University Hospitals NHS Trust, Oxford